Bharat Immunological & Biologicals Corporation Share Price
₹27.33 +2.65 (10.74%)
31 Jan, 2025 10:20
Start SIP in BIBCL
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 14.59%
- Over 3 Month + 14.11%
- Over 6 Month -14.94%
- Over 1 Year -15.67%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹27.33
+
2.65
(10.74%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹25.31
- 50 Day
- ₹25.43
- 100 Day
- ₹26.08
- 200 Day
- ₹27.09
Resistance and Support
24.52
- R3 25.58
- R2 25.17
- R1 24.93
- S1 24.28
- S2 23.87
- S3 23.63
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹27 As on 31 January, 2025 | 10:06
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹118 Cr As on 31 January, 2025 | 10:06
The P/E ratio of Bharat Immunological & Biologicals Corporation is -6.4 As on 31 January, 2025 | 10:06
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.3 As on 31 January, 2025 | 10:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.